Digital PCR (dPCR) and Realtime PCR (qPCR) Market size is expected to grow at a CAGR of 9% during the forecast period and the market size is expected to reach nearly USD 11.11 billion by 2030. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Dynamics:
With growing numbers of real-time PCR and qPCR consumers buying digital PCR because of the decrease in its cost, total quantification, better sensitivity, precision and better robustness; and with the qPCR and Digital PCR market projected to grow to US$ 4 billion by 2029, this conference delivers a timely occasion to learn first-hand about dPCR whereas also keeping up to date with latest enlargements and policies in qPCR and real-time PCR. Clinical applications of PCRs. According to the data from Centers for Disease Control and Prevention (CDC), the number of deaths because of cancers in U.S. was 575,000 in 2010 and estimated to rise to 630,000 in 2021. This is mostly because of morbid lifestyle, heredity, and others. So, growing number of cancer cases and associated deaths found to be one of the key causes for largest share of clinical application in global market.Digital PCR (dPCR) and Real-time PCR (qPCR) Market Regional Analysis:
North America is projected to be the largest market, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. Higher implementation of innovative technologies, well recognized healthcare research and diagnostic industries, growing funding for qPCR and dPCR technologies, rising incidence & prevalence of infective and genetic diseases, constant decrease in gene sequencing cost, and existence of key players in the region are responsible for largest share of North American market. At the same time, Asia Pacific is projected to grow at a fastest CAGR because of rapidly emerging countries, rising aging population coupled with increasing incidence of genetic diseases, increase in government support for life science research, developing research & clinical trial outsourcing from the region, and increasing number of CROs. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Digital PCR (dPCR) and Real-time PCR (qPCR) Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Digital PCR (dPCR) and Real-time PCR (qPCR) Market. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Highlights: 1. Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis and forecast, in terms of value. 2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Digital PCR (dPCR) and Real-time PCR (qPCR) Market 3. Digital PCR (dPCR) and Real-time PCR (qPCR) Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. 4. Digital PCR (dPCR) and Real-time PCR (qPCR) Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. 5. Digital PCR (dPCR) and Real-time PCR (qPCR) Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. 6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. 7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market are also profiled.Digital PCR (dPCR) and Real-time PCR (qPCR) Market Scope: Inquire before buying
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 6.08 Bn. Forecast Period 2024 to 2030 CAGR: 9% Market Size in 2030: US $ 11.11 Bn. Segments Covered: by Product Instruments Reagents Software Services by End User Hospitals Diagnostic Labs Academia Pharma-Biotech CRO by Application Clinical Oncology Forensics Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Digital PCR (dPCR) and Real-time PCR (qPCR) Market Key Players
1. Thermo Fisher Scientific, Inc. 2. F. Hoffman-La Roche Ltd. 3. Bio-Rad Laboratories, Inc. 4. QIAGEN N.V. 5. Takara Bio, Inc. 6. gilent Technologies, Inc. 7. bioMérieux S.A. 8. Fluidigm Corporation 9. Danaher Corporation 10.Abbott Laboratories 11.Merck KGaA 12.Becton Dickinson and Company 13.Promega Corporation 14.Eppendorf AG 15.Analytik Jena AG 16.Meridian Bioscience 17.Enzo Life Sciences 18.Bioneer 19.ELITech Group 20.Quidel Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market? Ans: The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is growing at a CAGR of 9% during forecasting period 2024-2030. 3. What is scope of the Global Digital PCR (dPCR) and Real-time PCR (qPCR) market report? Ans: Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Digital PCR (dPCR) and Real-time PCR (qPCR) market? Ans: The important key players in the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market are – Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., gilent Technologies, Inc., bioMérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, Analytik Jena AG, Meridian Bioscience, Enzo Life Sciences, Bioneer, ELITech Group, and Quidel Corporation. 5. What is the study period of this market? Ans: The Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market is studied from 2023 to 2030.
Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.2. Secondary data 2.3.3. Secondary Sources 2.3.4. Primary Research 2.3.5. Data from Primary Sources 2.3.6. Breakdown of Primary Sources 3. Executive Summary: Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends in Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market and Emerging Technologies 4.8. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Competitive Landscape 5. Supply Side and Demand Side Indicators 6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis and Forecast 6.1. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 7.4. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size (US$ Bn) Forecast, By Product 7.5. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, By Product 7.6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis, By Product 8. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 8.4. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size (US$ Bn) Forecast, By Application 8.5. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, By Application 8.6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis, By Application 9. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 9.4. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size (US$ Bn) Forecast, by End User 9.5. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by End User 9.6. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis, by End User 10. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Region 10.1. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Region 10.2. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size (US$ Bn) Forecast, by Region 10.3. Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis, by Region 11. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 11.1. Key Findings 11.2. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 11.3. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 11.4. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 11.4.1. Instruments 11.4.2. Reagents 11.4.3. Clinical 11.4.4. Forensics 11.5. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 11.6. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 11.6.1. Clinical 11.6.2. Oncology 11.6.3. Forensics 11.7. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 11.8. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 11.8.1. Hospitals 11.8.2. Diagnostic Labs 11.8.3. Academia 11.8.4. Pharma-Biotech 11.8.5. CRO 11.9. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Country 11.10. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Country 11.12. U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 11.12.1. Instruments 11.12.2. Reagents 11.12.3. Clinical 11.12.4. Forensics 11.13. U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 11.13.1. Clinical 11.13.2. Oncology 11.13.3. Forensics 11.14. U.S. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 11.14.1. Hospitals 11.14.2. Diagnostic Labs 11.14.3. Academia 11.14.4. Pharma-Biotech 11.14.5. CRO 11.15. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 11.15.1. Instruments 11.15.2. Reagents 11.15.3. Clinical 11.15.4. Forensics 11.16. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 11.16.1. Clinical 11.16.2. Oncology 11.16.3. Forensics 11.17. Canada Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 11.17.1. Hospitals 11.17.2. Diagnostic Labs 11.17.3. Academia 11.17.4. Pharma-Biotech 11.17.5. CRO 11.18. North America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Application 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Development 12. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 12.1. Key Findings 12.2. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 12.3. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 12.4. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.4.1. Instruments 12.4.2. Reagents 12.4.3. Clinical 12.4.4. Forensics 12.5. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 12.6. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.6.1. Clinical 12.6.2. Oncology 12.6.3. Forensics 12.7. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 12.8. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.8.1. Hospitals 12.8.2. Diagnostic Labs 12.8.3. Academia 12.8.4. Pharma-Biotech 12.8.5. CRO 12.9. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Country 12.10. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Country 12.12. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.12.1. Instruments 12.12.2. Reagents 12.12.3. Clinical 12.12.4. Forensics 12.13. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.13.1. Clinical 12.13.2. Oncology 12.13.3. Forensics 12.14. Germany Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.14.1. Hospitals 12.14.2. Diagnostic Labs 12.14.3. Academia 12.14.4. Pharma-Biotech 12.14.5. CRO 12.15. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.15.1. Instruments 12.15.2. Reagents 12.15.3. Clinical 12.15.4. Forensics 12.16. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.16.1. Clinical 12.16.2. Oncology 12.16.3. Forensics 12.17. U.K. Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.17.1. Hospitals 12.17.2. Diagnostic Labs 12.17.3. Academia 12.17.4. Pharma-Biotech 12.17.5. CRO 12.18. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.18.1. Instruments 12.18.2. Reagents 12.18.3. Clinical 12.18.4. Forensics 12.19. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.19.1. Clinical 12.19.2. Oncology 12.19.3. Forensics 12.20. France Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.20.1. Hospitals 12.20.2. Diagnostic Labs 12.20.3. Academia 12.20.4. Pharma-Biotech 12.20.5. CRO 12.21. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.21.1. Instruments 12.21.2. Reagents 12.21.3. Clinical 12.21.4. Forensics 12.22. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.22.1. Clinical 12.22.2. Oncology 12.22.3. Forensics 12.23. Italy Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.23.1. Hospitals 12.23.2. Diagnostic Labs 12.23.3. Academia 12.23.4. Pharma-Biotech 12.23.5. CRO 12.24. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.24.1. Instruments 12.24.2. Reagents 12.24.3. Clinical 12.24.4. Forensics 12.25. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.25.1. Clinical 12.25.2. Oncology 12.25.3. Forensics 12.26. Spain Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.26.1. Hospitals 12.26.2. Diagnostic Labs 12.26.3. Academia 12.26.4. Pharma-Biotech 12.26.5. CRO 12.27. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 12.27.1. Instruments 12.27.2. Reagents 12.27.3. Clinical 12.27.4. Forensics 12.28. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 12.28.1. Clinical 12.28.2. Oncology 12.28.3. Forensics 12.29. Rest of Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 12.29.1. Hospitals 12.29.2. Diagnostic Labs 12.29.3. Academia 12.29.4. Pharma-Biotech 12.29.5. CRO 12.30. Europe Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Application 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Development 13. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 13.1. Key Findings 13.2. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 13.3. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 13.4. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.4.1. Instruments 13.4.2. Reagents 13.4.3. Clinical 13.4.4. Forensics 13.5. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 13.6. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.6.1. Clinical 13.6.2. Oncology 13.6.3. Forensics 13.7. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 13.8. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.8.1. Hospitals 13.8.2. Diagnostic Labs 13.8.3. Academia 13.8.4. Pharma-Biotech 13.8.5. CRO 13.9. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Country 13.10. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Country 13.12. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.12.1. Instruments 13.12.2. Reagents 13.12.3. Clinical 13.12.4. Forensics 13.13. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.13.1. Clinical 13.13.2. Oncology 13.13.3. Forensics 13.14. China Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.14.1. Hospitals 13.14.2. Diagnostic Labs 13.14.3. Academia 13.14.4. Pharma-Biotech 13.14.5. CRO 13.15. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.15.1. Instruments 13.15.2. Reagents 13.15.3. Clinical 13.15.4. Forensics 13.16. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.16.1. Clinical 13.16.2. Oncology 13.16.3. Forensics 13.17. India Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.17.1. Hospitals 13.17.2. Diagnostic Labs 13.17.3. Academia 13.17.4. Pharma-Biotech 13.17.5. CRO 13.18. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.18.1. Instruments 13.18.2. Reagents 13.18.3. Clinical 13.18.4. Forensics 13.19. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.19.1. Clinical 13.19.2. Oncology 13.19.3. Forensics 13.20. Japan Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.20.1. Hospitals 13.20.2. Diagnostic Labs 13.20.3. Academia 13.20.4. Pharma-Biotech 13.20.5. CRO 13.21. ASEAN Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.21.1. Instruments 13.21.2. Reagents 13.21.3. Clinical 13.21.4. Forensics 13.22. ASEAN Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.22.1. Clinical 13.22.2. Oncology 13.22.3. Forensics 13.23. ASEAN Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.23.1. Hospitals 13.23.2. Diagnostic Labs 13.23.3. Academia 13.23.4. Pharma-Biotech 13.23.5. CRO 13.24. Rest of Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 13.24.1. Instruments 13.24.2. Reagents 13.24.3. Clinical 13.24.4. Forensics 13.25. Rest of Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 13.25.1. Clinical 13.25.2. Oncology 13.25.3. Forensics 13.26. Rest of Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 13.26.1. Hospitals 13.26.2. Diagnostic Labs 13.26.3. Academia 13.26.4. Pharma-Biotech 13.26.5. CRO 13.27. Asia Pacific Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Application 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Development 14. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 14.3. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 14.4. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 14.4.1. Instruments 14.4.2. Reagents 14.4.3. Clinical 14.4.4. Forensics 14.5. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 14.6. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 14.6.1. Clinical 14.6.2. Oncology 14.6.3. Forensics 14.7. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 14.8. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 14.8.1. Hospitals 14.8.2. Diagnostic Labs 14.8.3. Academia 14.8.4. Pharma-Biotech 14.8.5. CRO 14.9. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Country 14.10. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Country 14.12. GCC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 14.12.1. Instruments 14.12.2. Reagents 14.12.3. Clinical 14.12.4. Forensics 14.13. GCC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 14.13.1. Clinical 14.13.2. Oncology 14.13.3. Forensics 14.14. GCC Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 14.14.1. Hospitals 14.14.2. Diagnostic Labs 14.14.3. Academia 14.14.4. Pharma-Biotech 14.14.5. CRO 14.15. South Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 14.15.1. Instruments 14.15.2. Reagents 14.15.3. Clinical 14.15.4. Forensics 14.16. South Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 14.16.1. Clinical 14.16.2. Oncology 14.16.3. Forensics 14.17. South Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 14.17.1. Hospitals 14.17.2. Diagnostic Labs 14.17.3. Academia 14.17.4. Pharma-Biotech 14.17.5. CRO 14.18. Rest of Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 14.18.1. Instruments 14.18.2. Reagents 14.18.3. Clinical 14.18.4. Forensics 14.19. Rest of Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 14.19.1. Clinical 14.19.2. Oncology 14.19.3. Forensics 14.20. Rest of Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 14.20.1. Hospitals 14.20.2. Diagnostic Labs 14.20.3. Academia 14.20.4. Pharma-Biotech 14.20.5. CRO 14.21. Middle East & Africa Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Development 15. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis 15.1. Key Findings 15.2. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview 15.3. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Product 15.4. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 15.4.1. Instruments 15.4.2. Reagents 15.4.3. Clinical 15.4.4. Forensics 15.5. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, By Application 15.6. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 15.6.1. Clinical 15.6.2. Oncology 15.6.3. Forensics 15.7. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by End User 15.8. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 15.8.1. Hospitals 15.8.2. Diagnostic Labs 15.8.3. Academia 15.8.4. Pharma-Biotech 15.8.5. CRO 15.9. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Value Share Analysis, by Country 15.10. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Analysis, by Country 15.12. Brazil Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 15.12.1. Instruments 15.12.2. Reagents 15.12.3. Clinical 15.12.4. Forensics 15.13. Brazil Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 15.13.1. Clinical 15.13.2. Oncology 15.13.3. Forensics 15.14. Brazil Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 15.14.1. Hospitals 15.14.2. Diagnostic Labs 15.14.3. Academia 15.14.4. Pharma-Biotech 15.14.5. CRO 15.15. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 15.15.1. Instruments 15.15.2. Reagents 15.15.3. Clinical 15.15.4. Forensics 15.16. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 15.16.1. Clinical 15.16.2. Oncology 15.16.3. Forensics 15.17. Mexico Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 15.17.1. Hospitals 15.17.2. Diagnostic Labs 15.17.3. Academia 15.17.4. Pharma-Biotech 15.17.5. CRO 15.18. Rest of South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Product 15.18.1. Instruments 15.18.2. Reagents 15.18.3. Clinical 15.18.4. Forensics 15.19. Rest of South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, By Application 15.19.1. Clinical 15.19.2. Oncology 15.19.3. Forensics 15.20. Rest of South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Forecast, by End User 15.20.1. Hospitals 15.20.2. Diagnostic Labs 15.20.3. Academia 15.20.4. Pharma-Biotech 15.20.5. CRO 15.21. South America Digital PCR (dPCR) and Real-time PCR (qPCR) Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Application 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Development 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Thermo Fisher Scientific, Inc. 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Company Footprint 16.3.2. F. Hoffman-La Roche Ltd. 16.3.3. Bio-Rad Laboratories, Inc. 16.3.4. QIAGEN N.V. 16.3.5. Takara Bio, Inc. 16.3.6. gilent Technologies, Inc. 16.3.7. bioMérieux S.A. 16.3.8. Fluidigm Corporation 16.3.9. Danaher Corporation 16.3.10. Abbott Laboratories 16.3.11. Merck KGaA 16.3.12. Becton Dickinson and Company 16.3.13. Promega Corporation 16.3.14. Eppendorf AG 16.3.15. Analytik Jena AG 16.3.16. Meridian Bioscience 16.3.17. Enzo Life Sciences 16.3.18. Bioneer 16.3.19. ELITech Group 16.3.20. Quidel Corporation 17. Primary Key Insights